It is well appreciated that Ras is an integral signaling constituent of many growth factor receptor pathways and that alterations in several growth factor receptor pathways, including EGFR and PDGFR, are a dominant characteristic of glioblastoma. The gene discussed is EGFR; the disease is glioblastoma.